Nov. 1—Federal regulators have abandoned a plan that physicians, patients, and advocacy groups for breast cancer patients feared would limit women's options for reconstructive surgery. The controversy ...
Federal regulators have abandoned a plan that physicians, patients, and advocacy groups for breast cancer patients feared would limit women's options for reconstructive surgery. The controversy ...
The federal government is reconsidering a decision that breast cancer patients, plastic surgeons, and members of Congress have protested would limit women's options for reconstructive surgery. On June ...
CMS, the agency overseeing Medicare and Medicaid, maintains a list of codes representing thousands of medical services and products. It regularly evaluates whether to add codes or revise or remove ...
Federal regulators have abandoned a plan that physicians, patients and advocacy groups for breast cancer patients feared would limit women's options for reconstructive surgery. The controversy ...
The federal government is reconsidering a decision that breast cancer patients, plastic surgeons, and members of Congress have protested would limit women's options for reconstructive surgery. As of ...